Fundamental Analysis
26 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -98.5% | -59.5% | 1 / 3 | -17.9% | +2.27 pp | -54.74 pp | +0.4% | 0.50 | 220.80 | 94,8 | −17,9% | 1,0 | −98,5% | 220.80 | 10.28 | +2.047,8% |
| Pts | 0 | 0 | 4 | 0 | 8 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 16.500 (close price on 2026-10-19)EPS (TTM): 74,7
Financial charts
1.Revenue & growth
VND bn94,8Q2/26
1.Revenue & growth
VND bn94,8Q2/26
2.Profit & growth
VND bn0,56Q2/26
3.Profit mix (Penman)
VND bn1,48Q2/26
4.Margins & cost structure
%13.7%Q2/26
5.Returns & cash cycle
% · days1.4%Q2/26
6.Earnings quality & cash
VND bn1,42Q2/26
7.Asset structure
VND bn664Q2/26
8.Funding & debt health
VND bn · times664Q2/26
9.Revenue backlog
VND bn14,7Q2/26
10.Valuation
times · %296,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %27Q2/26
Adjusted EPS growth, latest quarter
-99.1%
Average adjusted EPS growth, 3 quarters
-59.7%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26